AAGHOTCPharmaceutical PreparationsFiscal year ends June 30

America Great Health

Financials through Q3 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 6, 2026

$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $12.69M
P/E (TTM): –
Dividend yield: –

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

America Great Health has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements America Great Health filed with the SEC

Aug 24, 2026, 4:08 PM ET
of a Clinical Observational Study of Ion-Modified Peptides
Other events · EX-99.1 to Form 8-K
Aug 24, 2026, 4:08 PM ET
1. Clinical Efficacy of Ion-Peptide Adjunctive Therapy in Patients
Other events · EX-99.2 to Form 8-K

Where these numbers come from

Parsed from the XBRL in America Great Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 10-for-1 split on Oct 10, 2012
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is AAGH.

Company	Revenue	Growth
AAGH	$363.33K	-5.1%
RGBP	$236.56K	0.0%
ABVC	–	–
SCNX	–	–
XCUR	$0	–
GDTC	–	–

Company

Exchange: OTC
Industry: Pharmaceutical Preparations
Fiscal year ends: June 30
Employees: 7
Auditor: Greengrowth CPAs
SEC CIK: 1098009

Advertisement
300 × 250